Literature DB >> 17011131

An outcome analysis of patients transferred to a regional burn center: transfer status does not impact survival.

Matthew B Klein1, Avery B Nathens, David M Heimbach, Nicole S Gibran.   

Abstract

BACKGROUND: Optimal burn care is provided at specialized burn centers. Given the geographic location of these centers, many burn patients receive initial treatment at local emergency departments prior to transfer. The purpose of this study was to determine whether patients transferred from other facilities have worse outcomes than those admitted directly from the field. STUDY
DESIGN: A retrospective cohort study was performed comparing the outcomes of patients admitted to our burn center directly from the field with patients requiring transfer from a preliminary care facility. The outcomes of interest were mortality, length of stay, length of stay/TBSA burned, number of operations and hospital charges. Poisson regression or Cox proportional hazards model was used to evaluate differences in outcomes after adjusting for potential confounders.
RESULTS: From 2000 to 2003 a total of 1877 patients were admitted to our burn center and 953 (51%) were transferred from a preliminary care facility. No difference (p<0.05) was found in length of stay, number of operations, hospital charges and mortality between the two cohorts.
CONCLUSIONS: This study demonstrates that patients transferred to a regional burn center from local hospitals have equivalent mortality, length of stay and hospital charges as those admitted directly from the field.

Entities:  

Mesh:

Year:  2006        PMID: 17011131     DOI: 10.1016/j.burns.2006.04.001

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  8 in total

1.  Time from accident to admission to a burn intensive care unit: how long does it actually take? A 25-year retrospective data analysis from a german burn center.

Authors:  J L Schiefer; A Alischahi; W Perbix; D Grigutsch; I Graeff; M Zinser; E Demir; P C Fuchs; A Schulz
Journal:  Ann Burns Fire Disasters       Date:  2016-03-31

2.  Influence of injury characteristics and payer status on burn treatment location in Washington state.

Authors:  Matthew B Klein; Christopher D Mack; C Bradley Kramer; David M Heimbach; Nicole S Gibran; Frederick P Rivara
Journal:  J Burn Care Res       Date:  2008 May-Jun       Impact factor: 1.845

3.  Adverse clinical outcomes associated with elevated blood alcohol levels at the time of burn injury.

Authors:  Geoffrey M Silver; Joslyn M Albright; Carol R Schermer; Marcia Halerz; Peggie Conrad; Paul D Ackerman; Linda Lau; Mary Ann Emanuele; Elizabeth J Kovacs; Richard L Gamelli
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

4.  Geographic access to burn center hospitals.

Authors:  Matthew B Klein; C Bradley Kramer; Jason Nelson; Frederick P Rivara; Nicole S Gibran; Thomas Concannon
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

5.  Does direct transport to provincial burn centres improve outcomes? A spatial epidemiology of severe burn injury in British Columbia, 2001-2006.

Authors:  Nathaniel Bell; Richard Simons; S Morad Hameed; Nadine Schuurman; Stephen Wheeler
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

6.  [Not Available].

Authors:  T Leclerc; C Hoffmann; E Forsans; A Cirodde; M Boutonnet; P Jault; J-P Tourtier; L Bargues; N Donat
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

7.  Burn related injuries: a nationwide analysis of adult inter-facility transfers over a six-year period in the United States.

Authors:  Christopher S Evans; Kimberly Hart; Wesley H Self; Sayeh Nikpay; Callie M Thompson; Michael J Ward
Journal:  BMC Emerg Med       Date:  2022-08-16

8.  Harborview burns--1974 to 2009.

Authors:  Loren H Engrav; David M Heimbach; Frederick P Rivara; Kathleen F Kerr; Turner Osler; Tam N Pham; Sam R Sharar; Peter C Esselman; Eileen M Bulger; Gretchen J Carrougher; Shari Honari; Nicole S Gibran
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.